KLOW
Janoshik
Batch KLOW-CA-26G-01
- GHK-Cu
- 63.68 mg
- TB-500 (TB4)
- 11.30 mg
- BPC-157
- 12.11 mg
- KPV
- 10.92 mg
KLOW
Multi-Peptide Research Blend
KLOW is a research blend formulated for investigation into combined metabolic and cellular signaling pathways in laboratory models. Studies typically focus on how its components may interact to influence energy regulation, tissue-related processes, and overall system-level responses within controlled experimental settings.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
KLOW is a multi-peptide research blend integrating GHK-Cu, BPC-157, TB-500, and KPV into a unified formulation developed for controlled laboratory investigation.
In scientific literature, these peptides are studied in experimental models examining cellular signaling pathways, inflammatory modulation frameworks, angiogenic activity, and extracellular matrix regulatory systems. The blend provides a research platform for exploring coordinated peptide interaction within tissue response and regenerative pathway models under in vitro and preclinical conditions.
The KLOW Blend integrates GHK-Cu, BPC-157, TB-500, and KPV into a unified research formulation designed for controlled laboratory study. Each component has been independently examined in preclinical settings involving structural pathway models, inflammatory signaling systems, and cellular response mechanisms.
Within experimental environments, the combined formulation is evaluated for its interaction across tissue remodeling pathways, angiogenic signaling models, extracellular matrix activity, and immune-related regulatory frameworks. The blend provides a structured platform for investigating multi-peptide pathway dynamics and coordinated cellular signaling processes under in vitro and preclinical conditions.
The individual peptides included in KLOW have been studied across several decades of laboratory research. GHK-Cu was first identified in the 1970s in studies examining copper-binding peptides. BPC-157 and TB-500 later emerged in structural peptide research frameworks, while KPV has been investigated within inflammatory signaling models.
KLOW represents a research-based integration of these peptides into a single experimental blend for controlled pathway evaluation.
Laboratory investigations involving the individual components of KLOW have explored structural pathway signaling, inflammatory response models, angiogenic activity frameworks, and extracellular matrix interactions. Research environments examine how multi-peptide systems influence coordinated cellular signaling under controlled in vitro and preclinical conditions.
1 of the 4 areas below are addressed directly by a paper cited on this page.
Structural and connective tissue pathway models
No paper cited on this page reports on structural, connective or tissue. This heading marks where KLOW is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Inflammatory signaling research frameworks
No paper cited on this page reports on inflammatory. This heading marks where KLOW is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Angiogenic pathway interaction studies
No paper cited on this page reports on angiogenic or interaction. This heading marks where KLOW is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Multi-peptide cellular communication models
Addressed on this page by Pickart 2015, Goldstein 2012, Sikiric 1993. The work appeared in Expert Opin Biol Ther and J Physiol Paris. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Pickart, L. et al. (2015) — GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.
- Goldstein, A.L. et al. (2012) — Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 12(1):37–51.
- Sikiric, P. et al. (1993) — A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
The references section of this page cites 7 primary papers published between 1993 and 2020 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for KLOW, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
KLOW is also referred to as KLOW blend, the klow stack.
KLOW is commonly described online in connection with faster healing from injury and improved recovery. In the research literature the same compound is filed under structural and connective tissue pathway models, inflammatory signaling research frameworks and angiogenic pathway interaction studies.
The 7 papers cited on this page, published between 1993 and 2020 (1 in animal models and 1 review) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
The lot code printed on the vial matches the code on the certificate for KLOW. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy KLOW in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
KLOW is a co-lyophilized blend — more than one compound freeze-dried together in a single vial. Handling follows the least stable component rather than an average, and the same is true of storage: the constraint that binds is whichever compound in the vial is most sensitive.
Reconstituting a blend does not separate its components, so a blend cannot be split into its parts after the fact. That is why per-component content verification matters more here than a single blended purity figure — the ratio inside the vial is fixed at manufacture and cannot be corrected downstream.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (80mg / Single Vial, 80mg / 5-Pack, 80mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 90mg of the KLOW peptide blend. Independent third-party testing verifies purity, identity, and batch composition prior to release.
The vial contains only the lyophilized peptide blend. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.
PubMedA new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedThymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 12(1):37–51.
PubMedThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985) 110(3):774–780.
PubMedPentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 19(11):19066–19077.
PubMedPepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134(1):166–178.
PubMedPentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. World J Hepatol 12(5):184–206.
PubMedRelated
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99